tirzepatide and pancreatitis Fatal, Fulminant, Necrotizing Associated With Recent Initiation Acute Pancreatitis Caused by Tirzepatide

Participants in structured trials lost up to 2022% of body weight, results that have understandably generated significant public interest

Gut bacteria Akkermansia is associated with reduced risk of obesity: evidence from the American Gut Project

In comparison to other GLP-1RAs, semaglutide was found to produce up to three times higher weight loss in type 2 diabetic patients and up to twice as much weight loss in obese patients, with some patients losing up to 15 kg

Glutathione has been shown to inhibit the production of pro-inflammatory cytokines, such as TNF- and IL-6, which are elevated in patients with RAS

For persistent symptoms, there are prescription medications available that can help reduce stomach acid and improve symptoms